Jupiter Life Line Hospitals Ltd
Wed 21/05/2025,15:42:55 | NSE : JLHL
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 1412.90
Previous Close
₹ 1412.70
Volume
35450
Mkt Cap ( Rs. Cr)
₹9327.42
High
₹ 1437.80
Low
₹ 1399.40
52 Week High
₹ 1770.00
52 Week Low
₹ 1067.65
Book Value Per Share
₹ 191.93
Dividend Yield
0.07
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Jupiter Life Line Hospitals Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Jupiter Life Line Hospitals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Jupiter Life Line Ho - Analysts/Institutional Investor Meet/Con. Call Updates
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Jupiter Life Line Ho - Analysts/Institutional Investor Meet/Con. Call Updates
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Jupiter Life Line Ho - Copy of Newspaper Publication
-
Jupiter Life Line Ho - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Jupiter Life Line Ho - Amalgamation OR Merger-XBRL
-
Jupiter Life Line Ho - Outcome of Board Meeting-XBRL
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Restructuring
-
Jupiter Life Line Ho - Amalgamation/Merger
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Jupiter Life Line Ho - Investor Presentation
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Change in Management
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Change in Management
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Cessation
-
Jupiter Life Line Ho - Cessation
-
Jupiter Life Line Ho - Appointment
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Change in Management
-
Jupiter Life Line Ho - Change in Management
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Change in Management
-
Jupiter Life Line Ho - Amendment to AOA/MOA
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Change in Management
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Change in Management
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Jupiter Life Line Ho - Change in Auditors
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Change in Management
-
Jupiter Life Line Ho - Change in Auditors
-
Jupiter Life Line Ho - Change in Auditors
-
Jupiter Life Line Ho - Appointment
-
Jupiter Life Line Ho - Dividend
-
Jupiter Life Line Ho - Board Meeting Outcome For The Quarter And Financial Year Ended March 31, 2025
-
Jupiter Life Line Ho - Board Meeting Outcome for Board Meeting Outcome For Quarter And Financial Year Ended March 31, 2025.
-
Jupiter Life Line Ho Q4 net profit up 3.01% at Rs 44.45 cr
-
Jupiter Life Line Ho - Outcome of Board Meeting
-
Jupiter Life Line Ho - Analysts/Institutional Investor Meet/Con. Call Updates
-
Jupiter Life Line Ho - Board Meeting Intimation
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Jupiter Life Line Ho - Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On Friday, May 09,
-
Jupiter Life Line Ho has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Jupiter Life Line Ho - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Jupiter Life Line Ho - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Jupiter Life Line Ho - Analysts/Institutional Investor Meet/Con. Call Updates
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Jupiter Life Line Ho - Disclosure under SEBI Takeover Regulations
-
Jupiter Life Line Ho - Agreements,Contracts,Arrangements,MOU-XBRL
-
Jupiter Life Line Ho - Agreements,Contracts,Arrangements,MOU-XBRL
-
Jupiter Life Line Ho - Trading Window-XBRL
-
Jupiter Life Line Ho - Trading Window
-
Jupiter Life Line Ho - Agreements
-
Jupiter Life Line Ho - Execution Of Loan Agreement
-
Jupiter Life Line Ho - Incorporation-XBRL
-
Jupiter Life Line Ho - General Updates
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Acquisition
-
Jupiter Life Line Ho - Analysts/Institutional Investor Meet/Con. Call Updates
-
Jupiter Life Line Ho - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Key fundamentals
Evaluate the intrinsic value of Jupiter Life Line Hospitals Ltd stock
Name | March-25 | March-24 | March-23 | March-22 | March-21 |
---|---|---|---|---|---|
Assets | 1497.542 | 1245.255 | 762.766 | 651.0125 | 511.488 |
Liabilities | 1497.542 | 1245.255 | 762.766 | 651.0125 | 511.488 |
Equity | 65.566 | 65.566 | 56.518 | 50.8666 | 50.8666 |
Gross Profit | 269.219 | 223.371 | 204.032 | 158.8504 | 69.0733 |
Net Profit | 184.702 | 151.953 | 107.214 | 84.6711 | 16.5931 |
Cash From Operating Activities | 219.878 | 109.791 | 184.029 | 142.345 | 113.1489 |
NPM(%) | 17.42 | 16.68 | 13.61 | 12.88 | 3.59 |
Revenue | 1059.998 | 910.633 | 787.322 | 657.2785 | 461.0955 |
Expenses | 790.779 | 687.262 | 583.29 | 498.4281 | 392.0222 |
ROE(%) | 14.67 | 12.07 | 8.51 | 6.72 | 1.31 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|---|---|---|---|
1 | 10 | 0.07 | 1421.7 | |
02 Aug 2024 | 1 | 10 | 0.07 | 1239.25 |
Peers
Other companies within the same industry or sector that are comparable to Jupiter Life Line Hospitals Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 810.15 | -0.84 | 26.88 | 805.31 | 301.39 | 0.62 |
Lotus Eye Hospital and Institute Ltd | 74.06 | 0.78 | 308.58 | 2934.46 | 14.01 | 0.68 |
Vaishali Pharma Ltd | 12.85 | -1.15 | 428.33 | 1512.53 | 2.76 | 0.00 |
Astec Lifesciences Ltd | 701.25 | -1.59 | 0.00 | 2766.94 | -687.11 | 0.00 |
Company Info
The Company was incorporated in Mumbai, Maharashtra, as `Jupiter Life Line Hospitals Limited', a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2002, issued by the RoC. the Company commenced its business on December 24, 2002.Major events and milestones of the Company :2007- Established and commenced operations of the first hospital at Thane, Maharashtra.2017- Established and commenced operations of the Pune Hospital.2018- Carried out interstitial brachytherapy to treat cancer at the Thane Hospital.2020- Acquired the Indore Hospital.2021- Successfully carried out small bowel intestine transplant surgery at the Thane, Hospital.2022- Successfully carried out heart transplant surgery at the Thane Hospital. 2022 -Jupiter Hospital, Pune has availed technical assistance for designing and constructing an energy efficient building. -Jupiter Hospital received Milestone Merits 2022 SAFETY Award. 2023 -Jupiter Life Line Hospitals received Community Care Excellence Award Jupiter Hospital Thane. -Jupiter Life Line Hospitals received Maharashtra State Best Employer Brand Award 2023. 2024 -The Company has acquired land in Bibvewadi, Pune, with an area of ~11,500 Sq. Meter, on a leased basis. The period for lease is 10 years.
The Company was incorporated in Mumbai, Maharashtra, as `Jupiter Life Line Hospitals Limited', a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2002, issued by the RoC. the Company commenced its business on December 24, 2002.Major events and milestones of the Company :2007- Established and commenced operations of the first hospital at Thane, Maharashtra.2017- Established and commenced operations of the Pune Hospital.2018- Carried out interstitial brachytherapy to treat cancer at the Thane Hospital.2020- Acquired the Indore Hospital.2021- Successfully carried out small bowel intestine transplant surgery at the Thane, Hospital.2022- Successfully carried out heart transplant surgery at the Thane Hospital. 2022 -Jupiter Hospital, Pune has availed technical assistance for designing and constructing an energy efficient building. -Jupiter Hospital received Milestone Merits 2022 SAFETY Award. 2023 -Jupiter Life Line Hospitals received Community Care Excellence Award Jupiter Hospital Thane. -Jupiter Life Line Hospitals received Maharashtra State Best Employer Brand Award 2023. 2024 -The Company has acquired land in Bibvewadi, Pune, with an area of ~11,500 Sq. Meter, on a leased basis. The period for lease is 10 years.
Read More
Parent Organisation
Jupiter Life Line Hospitals Ltd.
Founded
18/11/2002
Managing Director
Dr.Ankit Ajay Thakker
NSE Symbol
JLHLEQ
FAQ
The current price of Jupiter Life Line Hospitals Ltd is ₹ 1422.60.
The 52-week high for Jupiter Life Line Hospitals Ltd is ₹ 1437.80 and the 52-week low is ₹ 1399.40.
The market capitalization of Jupiter Life Line Hospitals Ltd is currently ₹ 9327.42. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Jupiter Life Line Hospitals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Jupiter Life Line Hospitals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Jupiter Life Line Hospitals Ltd shares.
The CEO of Jupiter Life Line Hospitals Ltd is Dr.Ankit Ajay Thakker, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.